Congress - Geneva, Switzerland
Oxford Global Conferences are proud to present the 5th Annual Drug Development Congress, taking place on the 10th & 11th June in Geneva.
It is estimated that the average drug costs the world’s leading pharmaceutical companies at least $4 billion to develop. Amid fears that the current large pharma model is not working, this event focuses on attempts to break down discovery and development boundaries and promote knowledge share between therapy areas.
On Day One, our expert speakers will discuss key areas for improvement in drug development, including translational modelling, safety & efficacy prediction and PK/PD testing. Delegates will also hear innovation case studies covering NGS applications in drug development and the development of the first approved gene therapy in Europe.
Day Two will cover current methods to improve decision making in drug development; from advances in biomarker technology, to the streamlining of sample analysis, to new knowledge management frameworks. Our expert speakers will also present collaboration case studies, discussing both external and internal attempts to harness complimentary skills and reduce late stage failure.
(Courtesy of logo of 5th Annual Drug Development Congress, via conferencehound.com)
For further information and upcoming events please visit www.oxfordglobal.co.uk
10th & 11th June, 2013
7-9 Chemin Du Petit-Saconnex, Geneva, 1211, Switzerland
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.